河马信号通路
生物
细胞生物学
激酶
抑制器
信号转导
可药性
功能(生物学)
信号转导衔接蛋白
支架蛋白
细胞骨架
细胞生长
磷酸化
细胞质
细胞
蛋白激酶A
癌细胞
癌症研究
辅活化剂
计算生物学
癌症
作者
Youchen Song,Liliana Attisano
标识
DOI:10.1101/cshperspect.a041900
摘要
AMP-activated protein kinase (AMPK)-related kinases, especially NUAK1 and NUAK2, have emerged as crucial modulators of Hippo signaling, linking cellular stress, mechanical tension, and metabolic cues to cell growth and survival. By transmitting these signals to the Hippo cascade, either by directly inhibiting large tumor suppressor 1 and 2 (LATS1/2) or by driving cytoskeletal remodeling, NUAKs effectively keep Yes-associated protein (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ) in an active state. Excessive expression or activity of NUAKs can dysregulate the Hippo pathway to drive disease, promoting oncogenesis, fibrosis, and contributing to other disorders. Thus, NUAK1 and NUAK2 are attractive, druggable therapeutic targets. Accordingly, small-molecule NUAK inhibitors are in development, several of which have been shown to reactivate Hippo signaling, restore YAP/TAZ cytoplasmic retention, and suppress aberrant cancer cell proliferation and fibrosis. Future work aimed at exploring NUAK regulation and function will not only provide new molecular insights in their mode of action but will also help guide the development of inhibitors that can restore Hippo pathway activity in diverse disease contexts.
科研通智能强力驱动
Strongly Powered by AbleSci AI